Sign Up to like & get
recommendations!
2
Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.925018
Abstract: Sirolimus (SRL) is a mammalian target of rapamycin (mTOR) inhibitor. The whole blood concentration of SRL is routinely monitored to tailor dosage and prevent toxicity. Currently, the enzyme multiplied immunoassay technique (EMIT) is often applied…
read more here.
Keywords:
srl;
children vascular;
comparison emit;
emit ... See more keywords